 |
|
Selection Factors Resulting in Improved Survival After Surgical Resection of Tumors Metastatic to the Lungs
Francesco M. Marincola, MD;
James B. D. Mark, MD
Arch Surg. 1990;125(10):1387-1393.
Abstract
| |
• From 1973 through 1987, a total of 140 patients underwent 184 operations for removal of metastatic tumors to the lungs. The number of lesions removed ranged from one to 30. Of the patients, 44% had solitary lesions. Overall 3-year survival was 62.6%, and 5-year survival was 48.2%. In all primary tumors except melanoma and breast cancer, 3-year survival was greater than 50% and 5-year survival was greater than 40%. With rare exceptions, the operation of choice for unilateral lesions was ipsilateral thoracotomy, and for bilateral lesions it was median sternotomy. Adequate conservative resection was the rule. There were three pneumonectomies, 25 lobectomies, 71 single wedge resections, 38 multiple unilateral wedge resections, and 47 bilateral wedge resections. There were no postoperative hospital deaths. Cox covariate analysis demonstrated improved survival in patients whose largest lesion was less than 1.5 cm in diameter and with disease-free interval longer than 1 year, but survival was not related to number of lesions or age of patient. An aggressive surgical approach is justified in patients with most primary tumors and a limited number of lung metastases less than 1.5 cm in diameter. Resection of metastases from melanoma and breast cancer should be accomplished after other sites of metastatic disease have been ruled out by the most stringent criteria.
(Arch Surg. 1990;125:1387-1393)
Author Affiliations
From the Division of Thoracic Surgery, Department of Surgery, Stanford (Calif) Medical Center.
Footnotes
Accepted for publication June 29, 1990.
Read before the 61st Annual Meeting of the Pacific Coast Surgical Association, Laguna Niguel, Calif, February 21, 1990.
Reprint requests to Stanford Medical Center, Room S283, Stanford, CA 94305 (Dr Mark).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gould et al.
Chest 2007;132:108S-130S.
ABSTRACT
| FULL TEXT
Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma
Kuo et al.
Ann. Surg. Oncol. 2007;14:992-997.
ABSTRACT
| FULL TEXT
The Surgical Management of Metastatic Melanoma
Allen and Coit
Ann. Surg. Oncol. 2002;9:762-770.
ABSTRACT
| FULL TEXT
Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest
Jaklitsch et al.
J. Thorac. Cardiovasc. Surg. 2001;121:657-667.
ABSTRACT
| FULL TEXT
Resection of pulmonary metastases in six patients with disease-free interval greater than 10 years
Kamiyoshihara et al.
Ann. Thorac. Surg. 1998;66:231-233.
ABSTRACT
| FULL TEXT
LONG-TERM RESULTS OF LUNG METASTASECTOMY: PROGNOSTIC ANALYSES BASED ON 5206 CASES
The International Registry of Lung Metastases et al.
J. Thorac. Cardiovasc. Surg. 1997;113:37-49.
ABSTRACT
| FULL TEXT
|
